288 related articles for article (PubMed ID: 1904112)
61. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
Madoiwa S
Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
[No Abstract] [Full Text] [Related]
62. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
63. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
64. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
Vervloet MG; Thijs LG; Hack CE
Semin Thromb Hemost; 1998; 24(1):33-44. PubMed ID: 9515778
[TBL] [Abstract][Full Text] [Related]
65. Disseminated intravascular coagulation in liver cirrhosis.
Bakker CM; Knot EA; Stibbe J; Wilson JH
J Hepatol; 1992 Jul; 15(3):330-5. PubMed ID: 1447499
[TBL] [Abstract][Full Text] [Related]
66. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].
Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y
Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451
[TBL] [Abstract][Full Text] [Related]
67. [The changes in molecular markers for hemostatic activation after t-PA therapy in case of pulmonary embolism].
Masuoka H; Hiraoka N; Inden M; Fujioka H; Konishi T; Nakano T; Deguchi K
Kokyu To Junkan; 1992 Apr; 40(4):407-10. PubMed ID: 1315073
[TBL] [Abstract][Full Text] [Related]
68. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
69. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia.
Sakata Y; Murakami T; Noro A; Mori K; Matsuda M
Blood; 1991 May; 77(9):1949-57. PubMed ID: 1708294
[TBL] [Abstract][Full Text] [Related]
70. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
[TBL] [Abstract][Full Text] [Related]
71. Increased levels of fibrinolysis reaction products (D-dimer) in patients with decompensated alcoholic liver cirrhosis.
Gram J; Duscha H; Zurborn KH; Bruhn HD
Scand J Gastroenterol; 1991 Nov; 26(11):1173-8. PubMed ID: 1754853
[TBL] [Abstract][Full Text] [Related]
72. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Yamada S; Asakura H
Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.
Asakura H; Wada H; Okamoto K; Iba T; Uchiyama T; Eguchi Y; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S
Thromb Haemost; 2006 Feb; 95(2):282-7. PubMed ID: 16493490
[TBL] [Abstract][Full Text] [Related]
74. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
75. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
Sakata T
Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
[No Abstract] [Full Text] [Related]
76. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
77. Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease.
Strano A; Hoppensteadt D; Walenga JM; Fareed J; Sabbá C; Berardi E; Allegra C; Carlizza A; Binaghi F; Fronteddu F; Del Guercio R; Del Guercio M; Pinto A; Alletto G; Nazzari M; Ferrari PA
Semin Thromb Hemost; 1996; 22 Suppl 1():35-40. PubMed ID: 8807727
[TBL] [Abstract][Full Text] [Related]
78. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
[TBL] [Abstract][Full Text] [Related]
79. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
80. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders.
Takahashi H; Tatewaki W; Wada K; Hanano M; Shibata A
Am J Hematol; 1990 Feb; 33(2):90-5. PubMed ID: 1689102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]